Irritable Bowel Syndrome Still Routinely Disrupts Patients' Lives

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, Aug. 12, 2025 -- Irritable bowel syndrome (IBS) symptoms disrupt affected patients' personal and professional lives an average of 19 days each month, according to the results of a poll released by the American Gastroenterological Association (AGA).

An online poll was conducted Oct. 28 to Nov. 8, 2024, and included 2,013 U.S. adults who have been diagnosed by a health care provider with IBS-constipation (1,005 individuals) or IBS-diarrhea (1,008) and have not been diagnosed with celiac disease, inflammatory bowel disease, ulcers, or colon, stomach, or other cancers of the gastrointestinal tract. A health care provider poll was conducted online between Nov. 15 and Dec. 9, 2024, among 600 health care providers, including gastroenterologists (200), primary care physicians (PCPs; 200), gastroenterology nurse practitioners/physician assistants (NP/PAs; 100), and PCP NP/PAs (100) who see at least six IBS patients per month.

According to the results of the poll, fewer patients reported their symptoms were currently very or extremely bothersome (43 percent in 2024 versus 62 percent in 2015), but 76 percent still found it somewhat or very difficult to manage their symptoms. Fewer than one in three patients reported they could accurately predict daily symptoms (31 percent in 2024 versus 29 percent in 2015). Nearly three in four (72 percent) said it was difficult to plan things because they never know when their symptoms will act up. More than 45 percent of health care providers said they usually or always recommend or prescribe an IBS treatment requested by their patients. Most patients with both IBS types (78 percent each) were satisfied with the treatments they currently took, but only about one in five were very satisfied.

"The findings of this survey underscore the persistent challenges and impact IBS has on patients' lives," Andrea Shin, M.D., an AGA patient education advisor, said in a statement. "Despite progress in the medical community’s approach to diagnosing and managing IBS, patients continue to suffer significant disruptions to their personal and professional lives."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords